Clinical Trial

Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive Esophagitis

Name: Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive Esophagitis — clinical trial record (NCT07732075)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects with Healed Erosive Esophagitis

Trial Details

NCT Number	NCT07732075
Lead Sponsor	Onconic Therapeutics Inc.
Conditions	Maintenance of Healed Erosive Gastroesophageal Reflux Disease (ERD)
Enrollment	384 participants
Start Date	2026-08-01
Primary Completion	2028-10-30 (estimated)
Study Completion	2028-10-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-28